BPG is committed to discovery and dissemination of knowledge
Opinion Review
Copyright: ©Author(s) 2026.
World J Gastroenterol. Jul 7, 2026; 32(25): 119116
Published online Jul 7, 2026. doi: 10.3748/wjg.119116
Figure 1
Figure 1 Reconsidering the role of metabolic dysfunction-associated steatotic liver disease in pancreatic cancer progression. MASLD: Metabolic dysfunction-associated steatotic liver disease.


Write to the Help Desk